Pompe disease drug wins EU approval
Tuesday April 11, 2006
On April 3, 2006, the European Medicines Agency (EMEA) granted marketing approval for the drug Myozyme (alglucosidase alfa) for treatment of Pompe disease in the European Union. Manufactured by Genzyme ... Read More